Abstract: Continuous glucose monitoring (CGM) devices offer diabetes patients a convenient approach to assist in controlling blood glucose levels. A prototype CGM has been developed that uses the emission profile of a polarity-sensitive fluorophore (acrylodan) conjugated to a glucose/ galactose-binding protein (SM4-AC) to measure the concentration of glucose in vivo. During development, a decrease in the devices signal intensity was observed in vivo over time, which was postulated to be result of oxidative degradation of SM4-AC. A comprehensive physicochemical analysis of SM4-AC was pursued to identify potential mechanisms of signal intensity loss in this CGM during in vitro forced oxidation studies. An assessment of the structural integrity and conformational stability of SM4-AC indicated a relatively decreased polarity and lower tertiary structure stability compared to unconjugated protein (SM4). The stability and polarity of SM4-AC was also altered in the presence of H 2 O 2 . Furthermore, a time-dependent loss in the fluorescence signal of SM4-AC was observed when incubated with H 2 O 2 . An LC-MS peptide mapping analysis of these protein samples indicated that primarily two Met residues in SM4-AC were susceptible to oxidation. When these two residues were genetically altered to an amino acid not prone to Abbreviations: AC, acrylodan; CD, circular dichroism; CGM, Continuous glucose monitor; DPBS, Dulbecco phosphate buffered saline; Fl, Fluorescence; LC-MS, liquid chromatography mass spectrometry; Ox,, Oxidation; RP-HPLC, reversed-phase high performance liquid chromatography; SM4, Glucose/galactose binding protein; T m , thermal melting temperature JMH and NS contributed equally to this work Importance Statement: A comprehensive physicochemical analysis of a sensor (glucose binding protein) used in a prototype continuous glucose monitor was pursued to identify potential mechanisms of signal intensity loss in vivo. The results of this study indicate that genetic alteration of two residues within the protein could increase the long-term stability of this device and therefore improve a patients' diabetes management. oxidation, the glucose binding ability of the protein was retained and no loss of acrylodan fluorescence was observed in the presence of H 2 O 2 . Genetic alteration of these two residues is proposed as an effective approach to increase the long-term stability of SM4-AC within this prototype CGM in vivo.
Introduction
Diabetes is chronic metabolic disease, affecting an estimated 9% of the world's population. 1 Diabetes is characterized by a deficient (type 1) or insufficient production (type 2) of insulin, which results in unregulated glucose levels in the body that can lead to numerous health issues and exacerbate other diseases. 2, 3 The overwhelming majority of these cases, especially in adults, is classified as type-2 diabetes and arises from obesity-related factors, including a poor diet and a sedimentary lifestyle. Mitigating abnormal glucose levels through the use of medications is requisite for disease management, and requires effective monitoring of patient's blood glucose levels. Historically sugar levels were monitored chemically from urine but modern devices measure the concentration of glucose directly from a patient's blood through the use of enzyme-based sensors (for review see Ref. 4) . These devices are lancetbased to draw blood, generally are self-administered by patients, and come in a variety of technologies by different manufacturers. 5 Although modern blood glucose monitors are precise, accurate, and sensitive, there remains a need for less-invasive and more patient-friendly devices to further improve diabetes management. An active field of diabetic research is focused on developing implantable continuous glucose monitoring (CGM) devices. A few of these devices are currently on the market in the US and primarily use glucose oxidase as a sensor of a patient's blood glucose profile. 6, 7 The disadvantage of these types of monitors is that the time between insertion and data readout can be long (1-10 hrs), and the accuracy of these devices in a patient experiencing hypoglycemia can be low. 8 Therefore, new generation
CGMs are in development that use alternative technologies (e.g., fluorescence, electromagnetic, reflectance) to monitor blood glucose levels in patients. 9 In the current study, the physicochemical mechanism(s) of a loss of signal in a glucose-binding protein used in a prototype CGM was examined through in vitro forced oxidation studies. The sensor in this system is based on the fluorescence of a polarity-sensitive probe (acrylodan, AC) conjugated to a genetically modified recombinant E. coli glucose/ galactose-binding protein (SM4). 8 The family of glucose/galactose binding proteins share a conserved two (a/b) 5 globular domain morphology linked through a hinge region. 10 Monosaccharides bind within a cleft in the hinge region (open conformation), causing substantial conformational changes within the protein (closed conformation). In SM4, AC is conjugated to a Cys residue (Cys 204 ) within the hinge region and glucose binding alters the intrinsic emission profile of the fluorophore. This variation in fluorescence can be used as a sensor to monitor the local concentration of glucose in a patient. During the development of this device, a decrease in fluorescence intensity was observed over time in vivo.
11 A preliminary investigation identified oxidative degradation of SM4-AC as a potential mechanism of AC fluorescence loss over time. In this study, a more comprehensive physicochemical analysis of SM4-AC was pursued using in vitro forced oxidation studies to identify the amino acid residues of SM4-AC involved in the in vivo loss of sensor activity.
Results

Physicochemical characterization
The biophysical characteristics of SM4, SM4-AC, and SM4-AC-Ox were examined to determine if the conjugation of AC or forced oxidation affected the physicochemical integrity and conformational stability of the SM4 protein. The overall secondary structure content of the three protein samples was characterized using Far-UV CD spectroscopy [ Fig. 1(A) ]. At 108C, each of the three proteins showed a mean residue molar ellipticity minimum at 208 and 222 nm, suggesting a primarily a-helical secondary structure. The mean residue molar ellipticity at 222 nm in each sample was then monitored as a function of temperature from 108C to 87.58C. The mean residue molar ellipticity intensity varied slightly between the three samples at 108C, likely because of instrumental variation, therefore each proteins molar ellipticity as a function of temperature was normalized to make any differences between the samples easier to visualize. The calculated thermal melting temperature (T m ) values of SM4, SM4-AC, and SM4-AC-Ox were 49.6 6 0.28C, 49.4 6 0.18C, and 46.0 6 0.28C, respectively. This indicated that oxidation, but not the conjugation of AC, destabilized the SM-4 proteins' conformational stability as measured by its overall secondary structure content. Intrinsic tryptophan fluorescence was used to monitor the overall tertiary structure of the three SM4 proteins [ Fig. 1(B) ]. At 108C, the emission maxima of the protein samples were 335 6 1 nm, which suggested a similar overall tertiary structure composition based upon the location of four Trp residues within the protein. Changes in the intrinsic fluorescence peak emission were also monitored as a function of temperature. As shown in Figure 1 (B), SM4-AC-Ox (T m : 46.4 6 0.8 C) and SM4-AC (T m : 47.8 6 0.9 C) were relatively less stable than SM4 (T m : 50.0 6 0.3 C). The similar T m between SM4-AC-Ox and SM4-AC suggested that AC conjugation destabilized the SM4 protein's overall tertiary structure, while the effect of incubating the protein for 1 hr at ambient temperature with 0.25% H 2 O 2 did not substantially influence the overall tertiary structure stability.
The three SM4 proteins were analyzed by RP-HPLC to monitor polarity changes induced by the fluorophore and H 2 O 2 -mediated oxidation. The representative RP-HPLC chromatogram of SM4 indicated a primarily homogenous species (Fig. 2) . SM4-AC eluted as two distinct species, in which the majority of the protein eluted later than SM4 and indicated an overall decrease in polarity upon conjugation. In contrast, SM4-AC-Ox was a heterogeneous mixture of species with generally increased polarity compared to SM4 or SM4-AC.
Glucose binding assay
The glucose binding ability of SM4-AC and SM4-ACOx was tested using an AC-fluorescence based assay. 8 Three different concentrations of glucose (0, 5, and 30 mM) were added to SM4-AC or SM4-AC-Ox (Fig.  3) . Five mM glucose represents a normal blood glucose level (3.5-5.5 mM 12 ) and therefore SM4 would be in an open and closed conformational equilibrium. Conversely, in the presence of 30 mM glucose, SM4 would exist primarily in a closed conformation. In the absence of glucose, SM4-AC had an emission maximum of 480 6 1 nm. In the presence of glucose, the fluorescence intensity decreased and a red shift to 490 6 1 nm (5 mM glucose) and 500 6 1 nm (30 mM glucose) was observed. Interestingly, oxidation of SM4-AC substantially altered the AC fluorescence emission profile. The oxidized sample did not show an emission maximum at 480 nm in the absence of glucose. Rather the fluorescence emission spectrum in all three samples of SM4-AC-Ox appeared red shifted to 490-500 nm and a substantial loss of fluorescence intensity was observed. These results indicate that oxidation reduced the intrinsic fluorescence of AC regardless of the presence or absence of glucose. Thus, the oxidized SM4-AC protein is either no longer able The fluorescence intensity of AC decreased as a function of incubation time in which 50% signal intensity was lost after 7 hrs [ Fig. 4(B) ]. In the absence of H 2 O 2 , the fluorescence intensity of SM4-AC with or without glucose did not change over the same time period (data not shown). These results demonstrate a correlation between SM4-AC oxidation and AC fluorescence intensity loss.
LC-MS peptide mapping was then used to identify amino acid residues susceptible to oxidation in SM4-AC. A sequence coverage of 85% was observed for all samples in which peptides containing seven of the eight Met residues in SM4-AC (which is an amino acid generally highly susceptible to oxidation) were identified. The UV 214nm peak areas of the peptides containing these nonoxidized and oxidized Met residues were quantified in each sample (Fig. 6) .
Based on these results, Met 199 and Met 203 appeared more susceptible to oxidation than the other Met residues in SM4-AC during forced oxidation. To better understand this effect, the AC-fluorescence chromatograms of SM4-AC without H 2 O 2 were and Met 203 oxidation and AC fluorescence loss.
As shown in Figure 6 , ) and the glucose binding ability of this mutant protein was compared to SM4-AC [ Fig.  7(A,B) ]. The acrylodan fluorescence emission maxima were similar between SM4-AC and SM4-AC M199L/M203L in the absence of glucose (479 6 1 nm) and in the presence of 5 mM (489 6 1 nm) and 30 mM (501 6 1 nm) glucose.
AC fluorescence in SM4-AC and SM4-AC M199L/ M203L was also monitored over time in the presence in SM4-AC and the loss of AC fluorescence changes in the presence of glucose during these forced oxidation studies.
Discussion
A comprehensive physicochemical analysis of an AC-conjugated and nonconjugated glucose/galactose binding protein (SM4 and SM4-AC) was performed, including in vitro forced oxidation studies, to identify potential mechanisms of a loss of the intrinsic fluorescence of this prototype CGM over time in vivo. Conjugation of the fluorophore destabilized the conformational integrity of SM4, and oxidation of the SM4-AC increased the polarity of the protein and had a more substantial destabilizing influence on the overall stability of the proteins' secondary structure relative to nonoxidized SM4 and SM4-AC. These observations were not necessarily unexpected, since AC was conjugated to one site on the protein 13 while oxidation is less specific and known to have substantial impacts on the conformation and stability of some proteins, depending on its location within the protein molecule. presumable alters the orientation of the fluorophore and/or exposes more of the glucose/galactose binding pocket to the surrounding solution. These changes could increase the local polarity surrounding AC and result in the observed decreased intensity and redshifted emission profile of SM4-AC-Ox. Oxidation could potentially be a cause of the lower signal intensity of this SM4-AC containing prototype glucose sensor over time in vivo. Neutrophils and monocytes are well known to release reactive oxidants (i.e., oxidative burst) during an acute inflammatory response to tissue damage, 16, 17 which is generated following surgical insertion of continuous glucose monitors in vivo. 18 These reactive oxygen species could oxidize Met 199 and Met 203 in SM4-AC and reduce the performance of this CGM in a patient over time. Reactive oxygen species have already been shown to reduce the stability of glucose oxidase-based sensors in vivo by oxidizing Met residues within the protein's active site. 19 Although advancements in biocompatible coatings and inclusion of anti-inflammatory drugs have improved the longevity of glucose monitors, 18 genetic alteration of these two Met residues to an amino acid less prone to oxidation could potentially be an effective approach to increase the long-term stability of this prototype CGM in vivo.
Conclusions
During development of a prototype CGM containing the conjugated SM4-AC protein, a decrease in the devices signal intensity was observed over time in vivo, which potentially appeared to be result of oxidative degradation. A comprehensive physicochemical analysis of SM4, SM4-AC, and SM4-AC-Ox during in vitro forced oxidation studies indicated that oxidation increases the polarity and decreases the conformational stability of the protein. H 2 O 2 -induced fluorescence loss in SM4-AC, which eliminated the ability to monitor glucose binding, correlated with the oxidation of two key residues in SM4-AC, Met 199 and Met
203
. Furthermore, mutating these two residues prevented fluorescence loss, and retained the ability to monitor glucose binding, compared to SM4-AC containing Met 199 and Met 203 during forced oxidation studies. In a companion paper, a candidate formulation was designed to increase the thermodynamic stability of SM4-AC for bulk storage (Sahni & Chaudhuri et al, in submission).
Methods and Materials
Materials
Sample preparation. Both the native recombinant glucose binding protein (SM4) and the acrylodan labeled glucose binding protein (SM4-AC) were produced in E. coli and provided by BD MedicalDiabetes Care in a buffer containing 10 mM MES (pH 5.5) and 30 mM glucose. 8 Construction, expres- plasmids were transformed into E. coli BL21 (DE3) cells. Following an overnight expression, the proteins were released from the cells through sonication and purified using a NiNTA column and an € AKTAxpress chromatography system (GE Healthcare Bio-Sciences, Pittsburgh, PA). Acrylodan was conjugated to the purified proteins by incubating 12 mM Acrylodan (in DMSO) with 2 mg/mL protein for 4 hrs at ambient temperature, then multiple rounds of dialysis into DPBS pH 7.4 with Ca 1 2 and Mg 1 2 (recipe procured from a commercial source, Cellgro, CellGenix, Breisgau, Germany) was performed to remove excess Acrylodan and DMSO.. All common reagents and chemicals were purchased from commercial sources. For physicochemical characterization, protein samples were dialyzed in 10 mM MES buffer pH 6.0, 150 mM NaCl. Oxidized SM4-AC (SM4-AC-Ox) was generated by incubating SM4-AC with 0.25% H 2 O 2 for 1 hr at ambient temperature and quenching the reaction with 1 mg of methionine.
Methods
Far-UV CD spectroscopy. Far-UV CD was performed using a Chirascan-plus Circular Dichroism Spectrometer (Applied Photophysics, Leatherhead, UK) equipped with a peltier temperature controller and a 4-position cuvette holder. The mean residue molar ellipticity of SM4, SM4-AC, and SM4-AC-Ox at 0.2 mg/mL were collected from 200 to 260 nm using a 0.1 cm path length cuvette. Thermal cycling was performed over a temperature range of 10-87.58C at 2.58C intervals and a heating rate of 18C/ min. The mean residue molar ellipticity at 222 nm was extracted to observe the change in secondary structure with increasing temperature. Baseline measurement of the buffer alone was taken and subtracted from an average of two separate sample measurements prior to data analysis. T m values were determined by a first derivative method using Origin 7.0 software (OriginLab, Northampton, MA).
Intrinsic tryptophan fluorescence spectroscopy. . The intrinsic tryptophan fluorescence of 0.2 mg/ mL SM4, SM4-AC, and SM4-AC-Ox was measured using a PTI spectrofluorometer (Photon Technology International, Birmingham, NJ). An excitation wavelength of 295 nm was used and the emission spectra were collected from 305 to 405 nm. The spectra were collected from 108C to 87.58C at 2.58C intervals with a 3 min equilibration time at each temperature. Data analysis was performed using FelixTM software (Photon Technology International). Experiments were performed in duplicate and the signal of the buffer alone was subtracted from the samples containing protein. The position of the emission wavelength maximum was determined using a mean spectral center of mass method (MSM) executed in Origin 7.0 software (OriginLab).
Reversed-phase (RP) HPLC. RP-HPLC separations were performed with a Shimadzu Prominence HPLC (Shimadzu Corporation, Tokyo, Japan) using a binary gradient of mobile phase A (0.1% TFA in water) and mobile phase B (0.1% TFA, 10% water, and 90% acetonitrile). Approximately 10 lg of each sample was loaded onto a 150 3 4.6 mm C18 column and associated guard column (Agilent Technologies) at 558C. Each protein was eluted with a linear gradient from 42.6% to 46.0% mobile phase B over 37 min and a flow rate of 1 mL/min. Protein peaks were monitored using the absorbance signal at 218 nm. Chromatograms were processed and visualized using LC solution software (Shimadzu Corporation).
Glucose binding assay. SM4-AC or SM4-AC-Ox were incubated with 0, 5, or 30 mM glucose. Glucose binding was observed using a PTI spectrofluorometer (Photon Technology International). An excitation wavelength of 390 nm was used and emission spectra were collected from 400 to 600 nm.
Acrylodan fluorescence quenching. SM4-AC was dialyzed into 13 DPBS buffer and incubated at 378C in the presence of 0.25% (v/v) H 2 O 2 and 5 mM glucose. The fluorescence intensity of AC was monitored over time (0-7 h) until a 50% loss was observed. Two control samples (1) SM4-AC with no H 2 O 2 and no glucose, and (2) SM4-AC with no H 2 O 2 but 5 mM glucose were also prepared in 13 DPBS buffer, pH 7.4. The oxidation reaction was quenched by adding D-Methionine. AC-fluorescence measurements were conducted as described above using a PTI spectrofluorometer (Photon Technology International) with an excitation wavelength of 390 nm. Emission spectra were collected from 400 to 600 nm. In a similar study, the AC fluorescence of SM4-AC WT and SM4-AC M199L/M203L were recorded under similar experimental conditions except that the samples were monitored for 0-5 h.
LC-MS peptide mapping. SM4-AC samples were incubated with 2.8 lg of trypsin (Promega, Madison, WI) in 25 mM ammonium bicarbonate, pH 8.0 at 378C for 4 h. TFA was then added (at 0.05% v/v) to quench proteolysis. The resulting peptide mixture was injected onto a liquid chromatography system (Thermo Scientific, Waltham, MA) equipped with an Acquity CSH130-C18 column (1.7 mm, 2.1 3 150 mm, Waters, Milford, MA). Peptides were separated using a 100 min 1-80% B gradient (mobile phase A: 0.05% TFA in water; mobile phase B: 0.05% TFA in acetonitrile; 200 lL/min flow rate). Mass spectroscopy was performed using a LTQ-XL ion trap (Thermo Scientific) and the Xcalibur 2.0 software (Thermo Scientific). The raw data files were processed using Proteome Discoverer software (Thermo Scientific). The database used for this experiment consisted of the SM4 and trypsin protein sequences. Potential Met oxidation and AC-conjugation at Cys 204 were included during the analysis. Peptide assignments of MS/MS spectra were validated using a Proteome Discoverer XCorr score of 2.0 and some manual validation.
